Clinical trials
Phase 1 Hematologic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| CASI pharmaceuticals, Inc. | 2 |
| University Health Network, Toronto | 2 |
| AbbVie | 1 |
| Gemin X | 1 |
| Hoffmann-La Roche | 1 |
| Jazz Pharmaceuticals | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Novartis | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 17 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Recurrence | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Multiple Myeloma | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Hodgkin Disease | 3 |
| Lymphoma | 3 |
| Lymphoma, T-Cell | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.